Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trump Praises Record Device Approvals, Pushes Congress To Pass 'Right-To-Try' Bills

Executive Summary

In his Jan. 30 State of the Union address, President Trump praised US FDA for its high approval rate of devices and drugs in 2017, and urged Congress to do more by approving 'right-to-try' legislation that he says would allow terminally ill patients to gain access to experimental devices and drugs.

Advertisement

Related Content

No-Device 'Right-To-Try' Bill Fails To Pass House Muster
No New US FDA Effort To Turn 'Right-To-Try' Bills Into Law
US Congress Ends Shutdown, Clinches Two-Year Device-Tax Repeal
Senate Adopts Cures Bill By Big Margin; FDA Could Tap $20m More In 2017
21st Century Cures: Device Provisions

Topics

Advertisement
UsernamePublicRestriction

Register

MT122132

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel